Abstract
While genome-wide association studies have been very successful in identifying associations of common genetic variants with many different traits, the rarer frequency spectrum of the genome has not yet been comprehensively explored. Technological developments increasingly lift restrictions to access rare genetic variation. Dense reference panels enable improved genotype imputation for rarer variants in studies using DNA microarrays. Moreover, the decreasing cost of next generation sequencing makes whole exome and genome sequencing increasingly affordable for large samples. Large-scale efforts based on sequencing, such as ExAC, 100,000 Genomes, and TopMed, are likely to significantly advance this field.
The main challenge in evaluating complex trait associations of rare variants is statistical power. The choice of population should be considered carefully because allele frequencies and linkage disequilibrium structure differ between populations. Genetically isolated populations can have favorable genomic characteristics for the study of rare variants.
One strategy to increase power is to assess the combined effect of multiple rare variants within a region, known as aggregate testing. A range of methods have been developed for this. Model performance depends on the genetic architecture of the region of interest.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Cohen J, Pertsemlidis A, Kotowski IK et al (2005) Low LDL cholesterol in African Americans resulting from frequent nonsense mutations in PCSK9. Nat Genet 37(3):328–328. https://doi.org/10.1038/ng0305-328c
Cohen JC, Boerwinkle E, Mosley TH (2006) Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. New Engl J Med 354(12):1264–1272. https://doi.org/10.1056/NEJMoa054013
Roth EM, McKenney JM, Hanotin C, Asset G, Stein EA (2012) Atorvastatin with or without an antibody to PCSK9 in primary hypercholesterolemia. New Engl J Med 367(20):1891–1900. https://doi.org/10.1056/NEJMoa1201832
Koren MJ, Scott R, Kim JB et al (2012) Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study. Lancet 380(9858):1995–2006. https://doi.org/10.1016/S0140-6736(12)61771-1
Timpson NJ, Walter K, Min JL et al (2014) A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans. Nat Commun 5:4871. https://doi.org/10.1038/ncomms5871
Gilly A, Ritchie GR, Southam L (2016) Very low-depth sequencing in a founder population identifies a cardioprotective APOC3 signal missed by genome-wide imputation. Hum Mol Genet 25(11):2360–2365. https://doi.org/10.1093/hmg/ddw088
Tachmazidou I, Dedoussis G, Southam L et al (2013) A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates. Nat Commun 4:2872. https://doi.org/10.1038/ncomms3872
Pollin TI, Damcott CM, Shen HQ et al (2008) A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent Cardioprotection. Science 322(5908):1702–1705. https://doi.org/10.1126/science.1161524
Jorgensen A, Frikke-Schmidt R, Nordestgaard BG, Tybjaerg-Hansen A (2014) Loss-of-function mutations in Apoc3 and reduced risk of ischemic vascular disease. Atherosclerosis 235(2):E18–E18
Crosby J, Peloso GM, Auer PL et al (2014) Loss-of-function mutations in APOC3, triglycerides, and coronary disease. New Engl J Med 371(1):22–31. https://doi.org/10.1056/NEJMoa1307095
Gaudet D, Alexander VJ, Baker BF et al (2015) Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia. New Engl J Med 373(5):438–447. https://doi.org/10.1056/NEJMoa1400283
Altshuler DM, Durbin RM, Abecasis GR et al (2015) A global reference for human genetic variation. Nature 526(7571):68–74. https://doi.org/10.1038/nature15393
UK10K Consortium, Walter K, Min JL et al (2015) The UK10K project identifies rare variants in health and disease. Nature 526(7571):82–90. https://doi.org/10.1038/nature14962
National Heart Lung and Blood Institute (2016) Trans-Omics for Precision Medicine (TOPMed) Program. https://www.nhlbi.nih.gov/research/resources/nhlbi-precision-medicine-initiative/topmed. Accessed 8 Nov 2016
Genomics England (2016) The 100,000 Genomes Project. https://www.genomicsengland.co.uk/the-100000-genomes-project/. Accessed 8 Nov 2016
Peplow M (2016) The 100 000 genomes project. BMJ 353. ARTN i1757. https://doi.org/10.1136/bmj.i1757
ExAC project pins down rare gene variants (2016). Nature 536(7616):249. https://doi.org/10.1038/536249a
Wang H, Liu L, Zhao J et al (2013) Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk. PLoS One 8(6):e67665. https://doi.org/10.1371/journal.pone.0067665
Gillespie JH (2010) Population genetics: a concise guide. Johns Hopkins University Press, Baltimore
Campbell MC, Tishkoff SA (2008) African genetic diversity: implications for human demographic history, modern human origins, and complex disease map**. Annu Rev Genomics Hum Genet 9:403–433. https://doi.org/10.1146/annurev.genom.9.081307.164258
Varilo T, Peltonen L (2004) Isolates and their potential use in complex gene map** efforts - commentary. Curr Opin Genet Dev 14(3):316–323. https://doi.org/10.1016/j.gde.2004.04.008
Minster RL, Hawley NL, Su CT et al (2016) A thrifty variant in CREBRF strongly influences body mass index in Samoans. Nat Genet 48(9):1049–1054. https://doi.org/10.1038/ng.3620
Steinthorsdottir V, Thorleifsson G, Reynisdottir I et al (2007) A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 39(6):770–775. https://doi.org/10.1038/ng2043
Holm H, Gudbjartsson DF, Sulem P et al (2011) A rare variant in MYH6 is associated with high risk of sick sinus syndrome. Nat Genet 43(4):316–320. https://doi.org/10.1038/ng.781
Huyghe JR, Jackson AU, Fogarty MP et al (2013) Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion. Nat Genet 45(2):197–201. https://doi.org/10.1038/ng.2507
Moltke I, Fumagalli M, Korneliussen TS et al (2015) Uncovering the genetic history of the present-day greenlandic population. Am J Hum Genet 96(1):54–69. https://doi.org/10.1016/j.ajhg.2014.11.012
Moltke I, Grarup N, Jorgensen ME et al (2014) A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes. Nature 512(7513):190–193. https://doi.org/10.1038/nature13425
Wetterstrand K (2016) DNA Sequencing Costs: Data from NHGRI Genome Sequencing Program (GSP). http://www.genome.gov/sequencingcostsdata. Accessed 28 Oct 2016
Yang J, Bakshi A, Zhu Z et al (2015) Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index. Nat Genet 47(10):1114–1120. https://doi.org/10.1038/ng.3390
McCarthy S, Das S, Kretzschmar W et al (2016) A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet 48(10):1279–1283. https://doi.org/10.1038/ng.3643
Abecasis G, Altshuler D, Boehnke M, et al (2016) Exome Chip. http://genome.sph.umich.edu/wiki/Exome_Chip_Design. Accessed 31 Oct 2016
Wessel J, Chu AY, Willems SM et al (2015) Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. Nat Commun 6:5897. https://doi.org/10.1038/ncomms6897
Peloso GM, Auer PL, Bis JC et al (2014) Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. Am J Hum Genet 94(2):223–232. https://doi.org/10.1016/j.ajhg.2014.01.009
Visscher PM, Brown MA, McCarthy MI et al (2012) Five years of GWAS discovery. Am J Hum Genet 90(1):7–24. https://doi.org/10.1016/j.ajhg.2011.11.029
Ionita-Laza I, McCallum K, Xu B et al (2016) A spectral approach integrating functional genomic annotations for coding and noncoding variants. Nat Genet 48(2):214–220. https://doi.org/10.1038/ng.3477
Ritchie GRS, Dunham I, Zeggini E et al (2014) Functional annotation of noncoding sequence variants. Nat Methods 11(3):294–U351. https://doi.org/10.1038/nmeth.2832
Kircher M, Witten DM, Jain P et al (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46(3):310–315. https://doi.org/10.1038/ng.2892
Ma C, Blackwell T, Boehnke M et al (2013) Recommended joint and meta-analysis strategies for case-control association testing of single low-count variants. Genet Epidemiol 37(6):539–550. https://doi.org/10.1002/gepi.21742
Bigdeli TB, Neale BM, Neale MC (2014) Statistical properties of single-marker tests for rare variants. Twin Res Hum Genet 17(3):143–150. https://doi.org/10.1017/thg.2014.17
Fisher RA (1922) On the interpretation of chi-squared from contingency tables, and the calculation of P. J R Stat Soc 85(1):87–94. https://doi.org/10.2307/2340521
Wang X (2014) Firth logistic regression for rare variant association tests. Front Genet 5:187. https://doi.org/10.3389/fgene.2014.00187
Lee S, Fuchsberger C, Kim S et al (2016) An efficient resampling method for calibrating single and gene-based rare variant association analysis in case-control studies. Biostatistics 17(1):1–15. https://doi.org/10.1093/biostatistics/kxv033
Auer PL, Reiner AP, Leal SM (2016) The effect of phenotypic outliers and non-normality on rare-variant association testing. Eur J Hum Genet 24(8):1188–1194. https://doi.org/10.1038/ejhg.2015.270
O'Connor TD, Kiezun A, Bamshad M et al (2013) Fine-scale patterns of population stratification confound rare variant association tests. PLoS One 8(7):e65834. https://doi.org/10.1371/journal.pone.0065834
Zhang Y, Shen X, Pan W (2013) Adjusting for population stratification in a fine scale with principal components and sequencing data. Genet Epidemiol 37(8):787–801. https://doi.org/10.1002/gepi.21764
Babron MC, de Tayrac M, Rutledge DN et al (2012) Rare and low frequency variant stratification in the UK population: description and impact on association tests. PLoS One 7(10):e46519. https://doi.org/10.1371/journal.pone.0046519
Liu Q, Nicolae DL, Chen LS (2013) Marbled inflation from population structure in gene-based association studies with rare variants. Genet Epidemiol 37(3):286–292. https://doi.org/10.1002/gepi.21714
Mathieson I, McVean G (2012) Differential confounding of rare and common variants in spatially structured populations. Nat Genet 44(3):243–246. https://doi.org/10.1038/ng.1074
Tintle N, Aschard H, Hu I et al (2011) Inflated type I error rates when using aggregation methods to analyze rare variants in the 1000 genomes project exon sequencing data in unrelated individuals: summary results from group 7 at genetic analysis workshop 17. Genet Epidemiol 35 Suppl 1:S56–S60. https://doi.org/10.1002/gepi.20650
International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437(7063):1299–1320. https://doi.org/10.1038/nature04226
Pe’er I, Yelensky R, Altshuler D et al (2008) Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol 32(4):381–385. https://doi.org/10.1002/gepi.20303
Dudbridge F, Gusnanto A (2008) Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 32(3):227–234. https://doi.org/10.1002/gepi.20297
Fadista J, Manning AK, Florez JC et al (2016) The (in)famous GWAS P-value threshold revisited and updated for low-frequency variants. Eur J Hum Genet 24(8):1202–1205. https://doi.org/10.1038/ejhg.2015.269
Sham PC, Purcell SM (2014) Statistical power and significance testing in large-scale genetic studies. Nat Rev Genet 15(5):335–346. https://doi.org/10.1038/nrg3706
Kryukov GV, Pennacchio LA, Sunyaev SR (2007) Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am J Hum Genet 80(4):727–739. https://doi.org/10.1086/513473
Nelson MR, Wegmann D, Ehm MG et al (2012) An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science 337(6090):100–104. https://doi.org/10.1126/science.1217876
Fu W, O'Connor TD, Jun G et al (2013) Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature 493(7431):216–220. https://doi.org/10.1038/nature11690
Bansal V, Libiger O, Torkamani A et al (2010) Statistical analysis strategies for association studies involving rare variants. Nat Rev Genet 11(11):773–785. https://doi.org/10.1038/nrg2867
Wu G, Zhi D (2013) Pathway-based approaches for sequencing-based genome-wide association studies. Genet Epidemiol 37(5):478–494. https://doi.org/10.1002/gepi.21728
Morris AP, Zeggini E (2010) An evaluation of statistical approaches to rare variant analysis in genetic association studies. Genet Epidemiol 34(2):188–193. https://doi.org/10.1002/gepi.20450
Morgenthaler S, Thilly WG (2007) A strategy to discover genes that carry multi-allelic or mono-allelic risk for common diseases: a cohort allelic sums test (CAST). Mutat Res 615(1–2):28–56. https://doi.org/10.1016/j.mrfmmm.2006.09.003
Li B, Leal SM (2008) Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet 83(3):311–321. https://doi.org/10.1016/j.ajhg.2008.06.024
Madsen BE, Browning SR (2009) A groupwise association test for rare mutations using a weighted sum statistic. PLoS Genet 5(2):e1000384. https://doi.org/10.1371/journal.pgen.1000384
Han F, Pan W (2010) A data-adaptive sum test for disease association with multiple common or rare variants. Hum Hered 70(1):42–54. https://doi.org/10.1159/000288704
Magi R, Asimit JL, Day-Williams AG et al (2012) Genome-wide association analysis of imputed rare variants: application to seven common complex diseases. Genet Epidemiol 36(8):785–796. https://doi.org/10.1002/gepi.21675
Zawistowski M, Gopalakrishnan S, Ding J et al (2010) Extending rare-variant testing strategies: analysis of noncoding sequence and imputed genotypes. Am J Hum Genet 87(5):604–617. https://doi.org/10.1016/j.ajhg.2010.10.012
Magi R, Kumar A, Morris AP (2011) Assessing the impact of missing genotype data in rare variant association analysis. BMC Proc 5(Suppl 9):S107. https://doi.org/10.1186/1753-6561-5-S9-S107
Asimit JL, Day-Williams AG, Morris AP et al (2012) ARIEL and AMELIA: testing for an accumulation of rare variants using next-generation sequencing data. Hum Hered 73(2):84–94. https://doi.org/10.1159/000336982
Hoffmann TJ, Marini NJ, Witte JS (2010) Comprehensive approach to analyzing rare genetic variants. PLoS One 5(11):e13584. https://doi.org/10.1371/journal.pone.0013584
Lin DY, Tang ZZ (2011) A general framework for detecting disease associations with rare variants in sequencing studies. Am J Hum Genet 89(3):354–367. https://doi.org/10.1016/j.ajhg.2011.07.015
Liu DJ, Leal SM (2010) A novel adaptive method for the analysis of next-generation sequencing data to detect complex trait associations with rare variants due to gene main effects and interactions. PLoS Genet 6(10):e1001156. https://doi.org/10.1371/journal.pgen.1001156
Price AL, Kryukov GV, de Bakker PI et al (2010) Pooled association tests for rare variants in exon-resequencing studies. Am J Hum Genet 86(6):832–838. https://doi.org/10.1016/j.ajhg.2010.04.005
Neale BM, Rivas MA, Voight BF et al (2011) Testing for an unusual distribution of rare variants. PLoS Genet 7(3):e1001322. https://doi.org/10.1371/journal.pgen.1001322
Basu S, Pan W (2011) Comparison of statistical tests for disease association with rare variants. Genet Epidemiol 35(7):606–619. https://doi.org/10.1002/gepi.20609
Lee S, Wu MC, Lin X (2012) Optimal tests for rare variant effects in sequencing association studies. Biostatistics 13(4):762–775. https://doi.org/10.1093/biostatistics/kxs014
Ladouceur M, Dastani Z, Aulchenko YS et al (2012) The empirical power of rare variant association methods: results from sanger sequencing in 1,998 individuals. PLoS Genet 8(2):e1002496. https://doi.org/10.1371/journal.pgen.1002496
Wu MC, Lee S, Cai T et al (2011) Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 89(1):82–93. https://doi.org/10.1016/j.ajhg.2011.05.029
Pan W (2009) Asymptotic tests of association with multiple SNPs in linkage disequilibrium. Genet Epidemiol 33(6):497–507. https://doi.org/10.1002/gepi.20402
Ionita-Laza I, Lee S, Makarov V et al (2013) Sequence kernel association tests for the combined effect of rare and common variants. Am J Hum Genet 92(6):841–853. https://doi.org/10.1016/j.ajhg.2013.04.015
Hasegawa T, Kojima K, Kawai Y et al (2016) AP-SKAT: highly-efficient genome-wide rare variant association test. BMC Genomics 17(1):745. https://doi.org/10.1186/s12864-016-3094-3
Lee S, Emond MJ, Bamshad MJ et al (2012) Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am J Hum Genet 91(2):224–237. https://doi.org/10.1016/j.ajhg.2012.06.007
Sun J, Zheng Y, Hsu L (2013) A unified mixed-effects model for rare-variant association in sequencing studies. Genet Epidemiol 37(4):334–344. https://doi.org/10.1002/gepi.21717
Li H, Chen J (2016) Efficient unified rare variant association test by modeling the population genetic distribution in case-control studies. Genet Epidemiol 40(7):579–590. https://doi.org/10.1002/gepi.21995
Moutsianas L, Agarwala V, Fuchsberger C et al (2015) The power of gene-based rare variant methods to detect disease-associated variation and test hypotheses about complex disease. PLoS Genet 11(4):e1005165. https://doi.org/10.1371/journal.pgen.1005165
Greco B, Hainline A, Arbet J et al (2016) A general approach for combining diverse rare variant association tests provides improved robustness across a wider range of genetic architectures. Eur J Hum Genet 24(5):767–773. https://doi.org/10.1038/ejhg.2015.194
Dering C, Konig IR, Ramsey LB et al (2014) A comprehensive evaluation of collapsing methods using simulated and real data: excellent annotation of functionality and large sample sizes required. Front Genet 5:323. https://doi.org/10.3389/fgene.2014.00323
Yi N, Zhi D (2011) Bayesian analysis of rare variants in genetic association studies. Genet Epidemiol 35(1):57–69. https://doi.org/10.1002/gepi.20554
Quintana MA, Berstein JL, Thomas DC et al (2011) Incorporating model uncertainty in detecting rare variants: the Bayesian risk index. Genet Epidemiol 35(7):638–649. https://doi.org/10.1002/gepi.20613
Chen LS, Hsu L, Gamazon ER et al (2012) An exponential combination procedure for set-based association tests in sequencing studies. Am J Hum Genet 91(6):977–986. https://doi.org/10.1016/j.ajhg.2012.09.017
Logsdon BA, Dai JY, Auer PL et al (2014) A variational Bayes discrete mixture test for rare variant association. Genet Epidemiol 38(1):21–30
Fan R, Wang Y, Mills JL et al (2013) Functional linear models for association analysis of quantitative traits. Genet Epidemiol 37(7):726–742. https://doi.org/10.1002/gepi.21757
Luo L, Zhu Y, **ong M (2012) Quantitative trait locus analysis for next-generation sequencing with the functional linear models. J Med Genet 49(8):513–524. https://doi.org/10.1136/jmedgenet-2012-100798
Luo L, Boerwinkle E, **ong M (2011) Association studies for next-generation sequencing. Genome Res 21(7):1099–1108. https://doi.org/10.1101/gr.115998.110
Fan R, Wang Y, Mills JL et al (2014) Generalized functional linear models for gene-based case-control association studies. Genet Epidemiol 38(7):622–637. https://doi.org/10.1002/gepi.21840
Vsevolozhskaya OA, Zaykin DV, Greenwood MC et al (2014) Functional analysis of variance for association studies. PLoS One 9(9):e105074. https://doi.org/10.1371/journal.pone.0105074
Fan R, Wang Y, Boehnke M et al (2015) Gene level meta-analysis of quantitative traits by functional linear models. Genetics 200(4):1089–1104. https://doi.org/10.1534/genetics.115.178343
Wang Y, Liu A, Mills JL et al (2015) Pleiotropy analysis of quantitative traits at gene level by multivariate functional linear models. Genet Epidemiol 39(4):259–275. https://doi.org/10.1002/gepi.21895
Wijsman EM (2012) The role of large pedigrees in an era of high-throughput sequencing. Hum Genet 131(10):1555–1563. https://doi.org/10.1007/s00439-012-1190-2
De G, Yip WK, Ionita-Laza I et al (2013) Rare variant analysis for family-based design. PLoS One 8(1):e48495. https://doi.org/10.1371/journal.pone.0048495
Ionita-Laza I, Lee S, Makarov V et al (2013) Family-based association tests for sequence data, and comparisons with population-based association tests. Eur J Hum Genet 21(10):1158–1162. https://doi.org/10.1038/ejhg.2012.308
Chen H, Meigs JB, Dupuis J (2013) Sequence kernel association test for quantitative traits in family samples. Genet Epidemiol 37(2):196–204. https://doi.org/10.1002/gepi.21703
Schaid DJ, McDonnell SK, Sinnwell JP et al (2013) Multiple genetic variant association testing by collapsing and kernel methods with pedigree or population structured data. Genet Epidemiol 37(5):409–418. https://doi.org/10.1002/gepi.21727
Feng S, Pistis G, Zhang H et al (2015) Methods for association analysis and meta-analysis of rare variants in families. Genet Epidemiol 39(4):227–238. https://doi.org/10.1002/gepi.21892
Svishcheva GR, Belonogova NM, Axenovich TI (2014) FFBSKAT: fast family-based sequence kernel association test. PLoS One 9(6):e99407. https://doi.org/10.1371/journal.pone.0099407
Oualkacha K, Dastani Z, Li R et al (2013) Adjusted sequence kernel association test for rare variants controlling for cryptic and family relatedness. Genet Epidemiol 37(4):366–376. https://doi.org/10.1002/gepi.21725
Jiang D, McPeek MS (2014) Robust rare variant association testing for quantitative traits in samples with related individuals. Genet Epidemiol 38(1):10–20. https://doi.org/10.1002/gepi.21775
Svishcheva GR, Belonogova NM, Axenovich TI (2015) Region-based association test for familial data under functional linear models. PLoS One 10(6):e0128999. https://doi.org/10.1371/journal.pone.0128999
Chen H, Lumley T, Brody J et al (2014) Sequence kernel association test for survival traits. Genet Epidemiol 38(3):191–197. https://doi.org/10.1002/gepi.21791
Cai T, Tonini G, Lin X (2011) Kernel machine approach to testing the significance of multiple genetic markers for risk prediction. Biometrics 67(3):975–986. https://doi.org/10.1111/j.1541-0420.2010.01544.x
Lin X, Cai T, Wu MC et al (2011) Kernel machine SNP-set analysis for censored survival outcomes in genome-wide association studies. Genet Epidemiol 35(7):620–631. https://doi.org/10.1002/gepi.20610
Fan R, Wang Y, Yan Q et al (2016) Gene-based association analysis for censored traits via fixed effect functional regressions. Genet Epidemiol 40(2):133–143. https://doi.org/10.1002/gepi.21947
Liu DJ, Leal SM (2015) Replicating sequencing-based association studies of rare variants. In: Zeggini E, Morris A (eds) Assessing rare variation in complex traits: design and analysis of genetic studies. Springer, New York, NY, pp 201–213. https://doi.org/10.1007/978-1-4939-2824-8_14
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Kuchenbaecker, K., Appel, E.V.R. (2018). Assessing Rare Variation in Complex Traits. In: Evangelou, E. (eds) Genetic Epidemiology. Methods in Molecular Biology, vol 1793. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7868-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7868-7_5
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7867-0
Online ISBN: 978-1-4939-7868-7
eBook Packages: Springer Protocols